Peritoneal Dialysis in Patients with Refractory Congestive Heart Failure: Potential Prognostic Factors

2013 ◽  
Vol 35 (4) ◽  
pp. 285-294 ◽  
Author(s):  
Margarita Kunin ◽  
Michael Arad ◽  
Dganit Dinour ◽  
Dov Freimark ◽  
Eli J. Holtzman
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Peritoneal Dialysis ◽  
Prognostic Factors

scholarly journals Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure

2011 ◽  
Vol 80 (9) ◽  
pp. 970-977 ◽  
Author(s):  
Florence Sens ◽  
Anne-Marie Schott-Pethelaz ◽  
Michel Labeeuw ◽  
Cyrille Colin ◽  
Emmanuel Villar
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Peritoneal Dialysis ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Survival Advantage ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals A neural network model for analysis of prognostic factors in congestive heart failure

1996 ◽  
Vol 27 (2) ◽  
pp. 358 ◽  
Author(s):  
Donna L. Hudson ◽  
Maurice E. Cohen ◽  
Rebecca J. Kanefield ◽  
Prakash C. Deedwania
Keyword(s):  
Neural Network ◽  
Heart Failure ◽  
Congestive Heart Failure ◽  
Prognostic Factors ◽  
Network Model ◽  
Neural Network Model

Variability in Case Mix and Peritoneal Dialysis Selection in Fifty-Nine French Districts

2008 ◽  
Vol 28 (5) ◽  
pp. 509-517 ◽  
Author(s):  
Cécile Couchoud ◽  
Emilie Savoye ◽  
Luc Frimat ◽  
Jean-Philippe Ryckelynck ◽  
Ylana Chalem ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Peritoneal Dialysis ◽  
Behavioral Disorders ◽  
Hierarchical Classification ◽  
Ratio Test ◽  
First Choice ◽  
Stage Renal Disease ◽  
Almost All ◽  
End Stage

In France, the use of peritoneal dialysis (PD) as the first-choice treatment varies greatly between districts, as it is already known to do between countries. Baseline clinical factors associated with choice of first modality were analyzed in 10815 new end-stage renal disease patients in 59 districts. To describe practices at the district level, we used an agglomerative hierarchical classification, with proximity defined by a likelihood-ratio test that compared multivariate logistic regressions of the following factors: age, gender, diabetes, congestive heart failure, severe behavioral disorders, mobility, and employment. To propose a typology, each cluster of districts was described by a multivariate logistic regression. While populations starting PD in France, as elsewhere, are more likely to be young or employed, they are also more likely to be elderly or have congestive heart failure or severe behavioral disorders. Overall, 14% of patients start with PD, but this rate varies significantly across districts, from 0% to 45%. A specific combination of factors was associated with the first-choice modality in each group of districts. This study highlights the lack of consensual medical criteria for this choice and the likelihood that nonmedical factors may explain the observed differences. The high variability suggests that PD can be used in almost all clinical conditions. Accordingly, patient preference should play a more important role in the decision-making process.

Peritoneal Dialysis in Refractory Congestive Heart Failure PART II: Continuous Ambulatory Peritoneal Dialysis (CAPD)

1983 ◽  
Vol 3 (3) ◽  
pp. 130-131 ◽  
Author(s):  
Michael Robson ◽  
Arie Biro Boleswar ◽  
Knobel George Schai ◽  
Mordchai Ravid
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Peritoneal Dialysis ◽  
Continuous Ambulatory Peritoneal Dialysis ◽  
Marked Improvement

Three patients with intractable congestive heart failure (CHF) resistant to all other therapy were treated for three, five and six months by continuous ambulatory peritoneal dialysis (CAPD). They lost eight to II kg in weight and had a marked improvement in symptoms of heart failure. Recurrent peritonitis precluded the continuation of CAPD and all three patients died within two weeks of stopping the treatment.

scholarly journals Effectiveness and Safety of Peritoneal Dialysis Treatment in Patients with Refractory Congestive Heart Failure due to Chronic Cardiorenal Syndrome

2018 ◽  
Vol 2018 ◽  
pp. 1-9 ◽  
Author(s):  
Qiuyuan Shao ◽  
Yangyang Xia ◽  
Min Zhao ◽  
Jing Liu ◽  
Qingyan Zhang ◽  
...  
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Peritoneal Dialysis ◽  
Survival Time ◽  
Heart Function ◽  
Cardiorenal Syndrome ◽  
Term Survival ◽  
Group A ◽  
Group B

Aims. To evaluate the effectiveness and safety of peritoneal dialysis (PD) in treating refractory congestive heart failure (RCHF) with cardiorenal syndrome (CRS).Methods. A total of 36 patients with RCHF were divided into type 2 CRS group (group A) and non-type 2 CRS group (group B) according to the patients’ clinical presentations and the ratio of serum urea to creatinine and urinary analyses in this prospective study. All patients were followed up till death or discontinuation of PD. Data were collected for analysis, including patient survival time on PD, technique failure, changes of heart function, and complications associated with PD treatment and hospitalization.Results. There were 27 deaths and 9 patients quitting PD program after a follow-up for 73 months with an average PD time of22.8±18.2months. A significant longer PD time was found in group B as compared with that in group A (29.0±19.4versus13.1±10.6months,p=0.003). Kaplan–Meier curves showed a higher survival probability in group B than that in group A (p<0.001). Multivariate regression demonstrated that type 2 CRS was an independent risk factor for short survival time on PD. The benefit of PD on the improvement of survival and LVEF was limited to group B patients, but absent from group A patients. The impairment of exercise tolerance indicated by NYHA classification was markedly improved by PD for both groups. The technique survival was high, and the hospital readmission was evidently decreased for both group A and group B patients.Conclusions. Our data suggest that PD is a safe and feasible palliative treatment for RCHF with type 2 CRS, though the long-term survival could not be expected for patients with the type 2 CRS. Registration ID Number isChiCTR1800015910.

scholarly journals Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation

2005 ◽  
Vol 20 (suppl_7) ◽  
pp. vii32-vii36 ◽  
Author(s):  
Lazaro Gotloib ◽  
Roberto Fudin ◽  
Michaela Yakubovich ◽  
Joerg Vienken
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Peritoneal Dialysis ◽  
End Stage

Peritoneal dialysis as a therapeutic approach in congestive heart failure resistant to pharmacological treatment

2009 ◽  
Vol 119 (12) ◽  
pp. 815-819
Author(s):  
Agnieszka Próchnicka ◽  
Anna Olszowska ◽  
Daniel Baczyński ◽  
Grzegorz Żelichowski ◽  
Zofia Wańkowicz
Keyword(s):  
Heart Failure ◽  
Congestive Heart Failure ◽  
Peritoneal Dialysis ◽  
Pharmacological Treatment ◽  
Therapeutic Approach

Peritoneal Dialysis in the Treatment of Cystic Fibrosis with Congestive Heart Failure

1966 ◽  
Vol 5 (12) ◽  
pp. 755-759 ◽  
Author(s):  
Stanley J. Stamm ◽  
Jack Doctor ◽  
Robert Rose ◽  
James Isbister ◽  
Robert Hickman
Keyword(s):  
Heart Failure ◽  
Cystic Fibrosis ◽  
Congestive Heart Failure ◽  
Peritoneal Dialysis
Sign in / Sign up

Export Citation Format

Share Document